Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced the launch of the U.S. Food and Drug ...

In contrast to normal prostatic epithelial cells, which are not able to regenerate and grow in an androgen-deprived state, prostate cancer cells almost always manage to acquire an androgen-independent ...

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases We note that there is an implicit, and often ...

The global compression therapy market is projected to expand at a CAGR of approximately 5% over the forecast period. Market growth is driven by the rising prevalence of venous and lymphatic disorders, ...